Annual Accounts Receivable
$15.44 M
+$2.74 M+21.56%
31 December 2023
Summary:
UroGen Pharma annual accounts receivable is currently $15.44 million, with the most recent change of +$2.74 million (+21.56%) on 31 December 2023. During the last 3 years, it has risen by +$8.40 million (+119.14%). URGN annual accounts receivable is now at all-time high.URGN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$22.80 M
+$5.39 M+30.93%
30 September 2024
Summary:
UroGen Pharma quarterly accounts receivable is currently $22.80 million, with the most recent change of +$5.39 million (+30.93%) on 30 September 2024. Over the past year, it has increased by +$9.96 million (+77.49%). URGN quarterly accounts receivable is now at all-time high.URGN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.6% | +77.5% |
| 3 y3 years | +119.1% | +192.9% |
| 5 y5 years | - | - |
URGN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +119.1% | at high | +192.9% |
| 5 y | 5 years | at high | at high | ||
| alltime | all time | at high | at high |
UroGen Pharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.80 M(+30.9%) |
| June 2024 | - | $17.41 M(+23.0%) |
| Mar 2024 | - | $14.16 M(-8.3%) |
| Dec 2023 | $15.44 M(+21.6%) | $15.44 M(+20.2%) |
| Sept 2023 | - | $12.85 M(-17.1%) |
| June 2023 | - | $15.51 M(+24.1%) |
| Mar 2023 | - | $12.49 M(-1.7%) |
| Dec 2022 | $12.70 M(+8.4%) | $12.70 M(+34.7%) |
| Sept 2022 | - | $9.43 M(-18.7%) |
| June 2022 | - | $11.60 M(+22.1%) |
| Mar 2022 | - | $9.50 M(-18.9%) |
| Dec 2021 | $11.72 M | $11.72 M(+50.5%) |
| Sept 2021 | - | $7.78 M(-18.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $9.51 M(+51.0%) |
| Mar 2021 | - | $6.30 M(-10.6%) |
| Dec 2020 | $7.05 M(>+9900.0%) | $7.05 M(+150.8%) |
| Sept 2020 | - | $2.81 M(+599.0%) |
| June 2020 | - | $402.00 K(>+9900.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2018 | - | $112.00 K(-51.7%) |
| June 2018 | - | $232.00 K(+5700.0%) |
| Mar 2018 | - | $4000.00(-88.2%) |
| Sept 2017 | - | $34.00 K(+240.0%) |
| June 2017 | - | $10.00 K(-88.0%) |
| Dec 2016 | $83.00 K(>+9900.0%) | $83.00 K |
| Dec 2015 | $0.00 | - |
FAQ
- What is UroGen Pharma annual accounts receivable?
- What is the all time high annual accounts receivable for UroGen Pharma?
- What is UroGen Pharma annual accounts receivable year-on-year change?
- What is UroGen Pharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for UroGen Pharma?
- What is UroGen Pharma quarterly accounts receivable year-on-year change?
What is UroGen Pharma annual accounts receivable?
The current annual accounts receivable of URGN is $15.44 M
What is the all time high annual accounts receivable for UroGen Pharma?
UroGen Pharma all-time high annual accounts receivable is $15.44 M
What is UroGen Pharma annual accounts receivable year-on-year change?
Over the past year, URGN annual accounts receivable has changed by +$2.74 M (+21.56%)
What is UroGen Pharma quarterly accounts receivable?
The current quarterly accounts receivable of URGN is $22.80 M
What is the all time high quarterly accounts receivable for UroGen Pharma?
UroGen Pharma all-time high quarterly accounts receivable is $22.80 M
What is UroGen Pharma quarterly accounts receivable year-on-year change?
Over the past year, URGN quarterly accounts receivable has changed by +$9.96 M (+77.49%)